跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Anzatax - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Anzatax
Approved
STANDARD
Anzatax
Hospira Australia Pty. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c6949156f8dced4c
Company
Hospira Australia Pty. Ltd.
Type
Standard
Approval Details
Approval Id
c6949156f8dced4c
Drug Approval Philippines Name
Anzatax
Product Name
Anzatax
Registration Number
DR-XY25441
Brand Name
Anzatax
Generic Name
Paclitaxel
Dosage Form
Solution for IV Infusion
Dosage Strength
6 mg/mL
Manufacturer
Hospira Australia Pty. Ltd.
Importer
Pfizer, Inc.
Distributor
Pfizer, Inc.
Importer Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Distributor Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Issuance Date
29 May 2025
Expiry Date
29 May 2030
Pharmacologic Category
Antineoplastic Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c6949156f8dced4c
Type
Standard
Back to Philippines FDA Approvals